Pocket-Sized liver scanner could replace bulky MRI machines
NCT ID NCT05986916
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 36 times
Summary
This study is testing a new, portable device called LiverScope that uses MRI-like technology to measure liver fat and other markers. Researchers will compare its accuracy to standard MRI and FibroScan in 50 adults with known or suspected nonalcoholic fatty liver disease (NAFLD). Participants undergo a one-time visit with scans and a blood draw. The goal is to see if this small, tabletop device can reliably diagnose liver disease outside of a hospital setting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NONALCOHOLIC FATTY LIVER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of California San Diego
La Jolla, California, 92037, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
LiverScope® exam
What this could lead to
If successful, this portable device could make liver disease diagnosis easier and more accessible, reducing the need for large MRI machines.
What could go wrong
This is a small, early-stage study (50 participants) focused on comparing measurements, not on treatment outcomes. The device is not yet approved for clinical use.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.